ranimustine has been researched along with Benign Hypothalamic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiguchi, H; Kageji, T; Kuroda, Y; Nagahiro, S; Okamoto, Y; Suzuya, H; Watanabe, T | 1 |
| Kagawa, T; Konishi, S; Moritake, K; Nagai, H; Nagao, S; Yamasaki, T | 1 |
2 other study(ies) available for ranimustine and Benign Hypothalamic Neoplasms
| Article | Year |
|---|---|
Successful high-dose chemotherapy for widespread neuroaxis dissemination of an optico-hypothalamic juvenile pilocytic astrocytoma in an infant: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Hypothalamic Neoplasms; Infant; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Nitrosourea Compounds; Optic Nerve Neoplasms; Peripheral Blood Stem Cell Transplantation; Syndrome | 2003 |
[The efficacy of granisetron as a prophylactic anti-emetic agent used in conjunction with MCNU and VP16 chemotherapeutic regimens in the management of a pediatric case of hypothalamic anaplastic astrocytoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Etoposide; Glioblastoma; Granisetron; Humans; Hypothalamic Neoplasms; Interferon-beta; Male; Nausea; Nitrosourea Compounds; Vomiting | 1995 |